Long-term effects of combined Chinese and Western medicine on ankylosing spondylitis
Follows adults with ankylosing spondylitis to track changes seen on scans over time.
Plain-language title generated from the registry record
Registry title: Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis (AS): A Cohort Study Protocol Focusing on Spondyloarthritis Research Consortium of Canada (SPARCC) Scoring System
Key facts
- Where
- Beijing, ChinaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 75 with ankylosing spondylitis or axial spondyloarthritis. It follows how the disease changes on imaging over time.
- Age
- 18 to 75 years
- Sex
- All sexes
- Disease stage
- Ankylosing spondylitis (1984 modified New York criteria) or axial spondyloarthritis (2009 ASAS criteria).
Main reasons for not taking part
- Another autoimmune disease, such as rheumatoid arthritis or Sjögren's syndrome
- Pregnancy or breastfeeding
- Severe heart or brain blood vessel disease, liver or kidney failure, or cancer
- Spondyloarthritis linked to bowel disease, psoriatic arthritis, or reactive arthritis
- Cannot give data because of mental or language reasons
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Source: NCT07509775, who can take part
Where in China
- China-Japan Friendship HospitalBeijing, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- China-Japan Friendship Hospital
- Trial code
- NCT07509775
- Record updated
- 9 April 2026
- Original description
This study is a multicentre, ambidirectional, observational cohort study. The ambidirectional design incorporates both the collection of retrospective data from the three years prior to enrolment, and a prospective follow-up period of up to two years. The study is designed to evaluate the long-term effects of Integrated Medicine on radiographic progression in patients diagnosed with Ankylosing spondylitis (AS).Read full original descriptionShow less
Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis: A Cohort Study Protocol Focusing on Spondyloarthritis Research Consortium of Canada (SPARCC) Scoring System
This study is a multicentre, ambidirectional, observational cohort study. The ambidirectional design incorporates both the collection of retrospective data from the three years prior to enrolment, and a prospective follow-up period of up to two years. The study is designed to evaluate the long-term effects of Integrated Medicine on radiographic progression in patients diagnosed with Ankylosing spondylitis (AS).
Inclusion: fulfill the 1984 modified New York criteria for ankylosing spondylitis or the 2009 Assessment of SpondyloArthritis International Society (ASAS) classification criteria for axial spondyloarthritis; age between 18 and 75 years; sign informed consent.
Exclusion: diagnosis of other autoimmune diseases besides the disease under investigation (e.g., rheumatoid arthritis, Sjögren's syndrome, erythema nodosum, myositis, etc.); comorbid severe cardiovascular or cerebrovascular diseases, hepatic or renal failure, or malignancy; pregnancy or lactation; spondyloarthritis related to enteropathic arthritis, psoriatic arthritis, or reactive arthritis; unable to provide data due to mental, language, or similar factors.